Hydroxocobalamin is a pharmaceutical form of vitamin B12 used to prevent and treat low B12 levels (including pernicious anemia) and, in intravenous form, as an antidote for cyanide poisoning. It is supplied as intramuscular injectable solutions (commonly 1,000 mcg/mL) for maintenance and replacement therapy and as a 5 g powder for IV reconstitution (marketed as Cyanokit) for emergency use. Target users include patients with dietary lack or malabsorption of B12 and clinicians managing suspected cyanide exposure.
This review synthesizes prescribing and safety information from authoritative clinical sources: WebMD (hydroxocobalamin for B12 replacement and common adverse effects), Drugs.com (dosage forms, brand names, and cyanide-antidote use), Mayo Clinic (IV Cyanokit use and emergency administration guidance), and Cleveland Clinic (role in preventing and treating low B12). No primary clinical trials or user testimonials outside these sources were used.
High-level verdict: hydroxocobalamin performs the functions expected of a B12 injectable—reliable parenteral repletion and a unique role as a cyanide antidote when provided as a 5 g IV product—but the clinical trade-offs are clear. Strengths are clinical versatility (IM for maintenance; IV 5 g powder for emergencies) and established mechanisms. Downsides are the need for clinician administration for IV use, common injection-site pain, and dermatologic reactions (including an acne-like rash appearing 1–4 weeks post-treatment) plus the small risk of allergic reactions.
What is hydroxocobalamin used for?
Hydroxocobalamin is used to maintain or restore vitamin B12 levels in patients who do not get enough B12 from diet or cannot absorb it (including pernicious anemia), and historically in diagnostic contexts such as the Schilling test. Clinical sources list both replacement therapy and prevention/treatment of low B12 levels as primary indications.
Separately, in intravenous form (notably the 5 g powder marketed as Cyanokit), hydroxocobalamin is approved and used as an emergency antidote for known or suspected cyanide poisoning—situations such as smoke inhalation from closed-space fires or industrial cyanide exposure where rapid administration is required.
Available formulations and typical doses
Referenced formulations include an injectable solution commonly labelled at 1,000 mcg/mL for intramuscular use and a 5 g powder for intravenous reconstitution (Cyanokit). These distinct presentations reflect two clinical pathways: routine parenteral B12 replacement and emergency IV cyanide antidote dosing.
Because formulations and indications differ (IM maintenance vs IV emergency), clinicians select product and route according to indication—routine deficiency management generally uses the IM 1,000 mcg/mL injections, while suspected cyanide toxicity requires the 5 g IV powder preparation under medical supervision.
Known adverse effects and safety considerations
Commonly reported adverse effects across clinical sources include injection-site pain, diarrhea, rash, and itching. A distinctive dermatologic effect is an acne-like skin rash that can appear within 1–4 weeks after treatment and typically resolves without intervention. Serious allergic reactions are rare but possible—watch for hives, facial or throat swelling, and breathing difficulty.
For IV cyanide-antidote use, the Mayo Clinic emphasizes that hydroxocobalamin should be given only by or under the supervision of a physician. Drugs.com also lists more severe potential events (e.g., bright red stools or cardiovascular complaints) as signals to seek immediate care; therefore monitoring and follow-up lab work are recommended during treatment.
How it’s given and practical considerations
Intramuscular hydroxocobalamin is given by injection into muscle; patients receiving routine replacement should keep appointments for lab monitoring of B12 levels. The IV form (5 g powder) is reconstituted and administered in emergency settings for suspected cyanide poisoning and requires trained clinical staff for preparation and infusion.
Practical implications: patients should expect injection-site discomfort with IM use, and the IV antidote will likely cause acute color changes (reported indirectly in clinical materials) and requires hospital resources. Self-administration is not appropriate for the IV cyanide-antidote form.
How hydroxocobalamin compares with other B12 options
Cyanocobalamin is another commonly used form of vitamin B12 referenced in the clinical literature; it is available in injectable and oral forms and may be preferred where non-hospital administration or oral therapy is adequate. Hydroxocobalamin’s key differentiator is the 5 g IV formulation for cyanide antidote use.
Choice between hydroxocobalamin and other B12 preparations depends on indication: use hydroxocobalamin IM when parenteral replacement is needed and prefer the IV 5 g product only for cyanide exposure under clinician care; for routine, easily absorbed deficiencies, oral cyanocobalamin formulations remain alternatives.
Pros & Cons
- ✅ Dual clinical roles: parenteral B12 replacement (IM 1,000 mcg/mL) and an emergency 5 g IV powder antidote for cyanide poisoning (Cyanokit).
- ✅ Available in defined, clinically used concentrations: 1,000 mcg/mL injectable solution and a 5 g IV powder (explicitly cited in prescribing sources).
- ✅ Clinically effective mechanism for cyanide: converts cyanide to a renally excretable form (documented antidote action).
- ✅ Recognized by major clinical sources (Mayo Clinic, Cleveland Clinic, WebMD) with clear administration protocols for both routine and emergency use.
- ❌ Injection-related adverse effects are common (pain at the injection site, diarrhea, rash, itching reported in patient information).
- ❌ Acne-like skin rash can appear within 1–4 weeks post-treatment and may be distressing despite being self-limited.
- ❌ Rare but serious allergic reactions have been reported (hives, facial/throat swelling, breathing difficulty), requiring emergency care.
- ❌ IV cyanide-antidote form requires hospital administration and clinician supervision; not suitable for self-administration.
How It Compares to the Competition
- Cyanokit (hydroxocobalamin IV powder) — Same active molecule but presented specifically for emergency IV cyanide antidote use; requires hospital use and rapid reconstitution.
- Cyanocobalamin injections (generic) — Alternative injectable form of vitamin B12 used for replacement; lacks the specific 5 g IV cyanide-antidote formulation.
- Oral cyanocobalamin tablets — Non-injectable option for patients with dietary deficiency or intact absorption; avoids injection-site pain but unsuitable for severe malabsorption or cyanide poisoning.
Who Should Buy This & Who Should Skip It
Buy it if: Patients diagnosed with vitamin B12 deficiency who require parenteral replacement (for example, pernicious anemia or malabsorption) and clinicians who need an evidence-based IV antidote option for suspected cyanide poisoning should consider hydroxocobalamin products. Use should be under prescription and appropriate clinical supervision.
Skip it if: People who can correct mild vitamin B12 deficiency with oral cyanocobalamin, those who strongly prefer to avoid injections, and anyone with a history of severe allergic reaction to cobalamin compounds should discuss alternatives with their clinician before choosing hydroxocobalamin.
Search Purchase Options
Use these links to search for Hydroxocobalamin injections (various brands) on trusted marketplaces. The links open in new tabs; if you buy through them, we may earn a commission at no extra cost to you.
* Affiliate links: you pay the same price either way.